CARE CHC National Report

The 8th annual Canadian Hematology Conference took place on September 28th and 29th, 2018 in Toronto, Ontario. Over 30 Canadian and international opinion leaders presented, providing highly informative, cutting-edge presentations on a variety of hematological topics. 

This year’s conference agenda was designed to cover the most exciting and important categories in hematology, while also providing insights and information relevant to Canadian practice. This CHC 2018 Conference Report provides a summary of the robust content presented during the two-day conference.  Presentations and subsequent discussion content covered both malignant and benign hematology, involving academics, clinicians, trainees and allied health providers. 

Regional CHC meetings were subsequently held in Calgary and Vancouver covering highlights from CHC National with province-specific topics of interest. (A Montreal iteration will follow in early 2019). 

CARE Access to Innovation Position Statement

Access Position Statement 2018.png

 Members of the CARE™ Hematology and Oncology Faculty met at ASCO (Chicago, June); EHA (Stockholm, June) and CUA (Halifax, June) to consider a CARE™ position statement regarding access to innovative therapies in Canada. These working groups were augmented with ad hoc sessions in Toronto and Hamilton for faculty who were unable to attend these sessions. 

CARE Perspectives on ASCO EHA 2018

ASCO & EHA REPORT 2018.png

Select members of the CARE™ Faculty attended the 2018 ASCO (American Society for Clinical Oncology) meeting, held in Chicago, IL from June 1st to 5th and the annual EHA (European Hematology Association) meeting held in Stockholm Sweden, June 14th to 17th. 

This report features updates from the 2018 ASCO and EHA Conferences augmented with CARE ™ Faculty Perspectives. It also provides highlights from recent CARE™ programs including multiple Needs Assessments. 

This report focuses on hematological cancers and features coverage on Multiple Myeloma, Waldenström Macroglobulinemia, Non-Hodgkin’s Lymphoma, Mantle Cell Lymphoma, Chronic Lymphocytic Leukemia and Stem Cell Transplant/Cell Therapy. 

Content is drawn from the ASCO/EHA 2018 meetings and is written in the language in which it was presented. 

CARE Hematology Faculty who have contributed to this report:

Dr. Kevin Song
BC Cancer Agency

Dr. Peter Anglin
Southlake Regional Health Centre

Dr. John Kuruvilla
Princess Margaret Cancer Centre

Dr. Dennis Kim
Princess Margaret Cancer Centre

CARE Perspectives on Tandem 2018


This CARE Perspectives conference report has been developed by the CARE Hematology Faculty who recently attended the 2018 Bone and Marrow Transplantation (BMT) Tandem Meetings (Tandem 2018) held in Salt Lake City, UT. Presented from a Canadian perspective, this education piece provides a summary of compelling stories and news presented at Tandem 2018 augmented by a recent publication from the European Myeloma Network (EMN).

CARE Hematology Faculty who have contributed to this report: 

John Kuruvilla, MD
Princess Margaret Cancer Centre

Dennis Kim, MD
Princess Margaret Cancer Centre

CARE Ontario Winter Hematology Update Meeting Report


The inaugural CARE Winter Hematology Update took place on February 23rd, 2018 at the Shangri-La Hotel in Toronto, Ontario. CARE was pleased to welcome an excellent Faculty of Canadian key opinion leaders (KOLs) with expertise in a diverse set of hematological diseases. Members of the CARE Hematology Faculty presented updates from ASH 2017 and other key hematological news framed from a Canadian perspective.

This CARE meeting featured an exciting set of presentations covering the most impactful hematological topics, along with CARE Working Group Meetings - for smaller KOL groups to have focused, extended, discussions. The CARE Working Groups focused on managing CLL, MCL, ALL, MM, and WM in Canada.

CARE (Community Academic Research Education) believes in accessibility, competition, innovation with new treatments and the optimization of current therapy- with the goal of improving patient outcomes. CARE initiatives aim to educate Canadian health care professionals by providing updates on relevant medical news and developments, framed from a Canadian perspective.

CARE Hematology Faculty who have contributed to this report:

Meeting Chairs: 

Dr. John Kuruvilla (Princess Margaret Cancer Centre)
Dr. Peter Anglin (Stronach Regional Cancer Centre)  

Presenters and Authors: 

Chronic Lymphocytic Leukemia (CLL) - Dr. Graeme Fraser (Juravinski Cancer Center) 
Hodgkin’s Lymphoma (HL) - Dr. John Kuruvilla (Princess Margaret Hospital)
Multiple Myeloma (MM) - Dr. Christine Chen (Princess Margaret Hospital)
Myeloid Disorders and Transplant  - Dr. Dennis Kim (Princess Margaret Hospital)
Non-Hodgkin’s Lymphoma (NHL) - Dr. Michael Crump (Princess Margaret Hospital)
Cell Therapy: CAR-T Focus - Dr. Ronan Foley (McMaster University)  
Emerging Concepts in Cell Therapy - Dr. Rob Laister (Princess Margaret Hospital)

CARE Management Considerations Reports

Members of the CARE Ontario Hematology Faculty held Working Group meetings in conjunction with the CARE Winter Hematology Meeting - ASH Update on February 23rd in Toronto. During these meetings relevant news and data were considered from an Ontario perspective in the areas of multiple myeloma (MM), Waldenström’s macroglobulinemia (WM), chronic lymphocytic leukemia (CLL), mantle cell lymphoma (MCL) and acute lymphocytic leukemia (ALL). 

CARE Perspectives on ASH 2017

ASH 2017.png

Highlights from ASH 2017

Members of the CARE Hematology Faculty recently attended the American Society of Hematology (ASH) conference held in Atlanta, Georgia from December 9th-12th, 2017. CARE Faculty Chairs, Dr. Diego Villa and Dr. Martina Trinkaus also hosted the 12th annual CARE at ASH Resident and Trainee Education Meeting in conjunction with the conference. This was a highly successful meeting with participation from over 130 hematology professionals (residents and specialist faculty). For more information in this event and for additional CARE at ASH resources please click here.

This issue of CARE Perspectives from ASH 2017 provides a summary of the most exciting and relevant stories presented at both the American Society of Hematology conference 2017 and the CARE at ASH 2017 meeting. Abstract content is augmented with additional perspectives from select CARE at ASH presenting Faculty, including Drs. Graeme Fraser (CLL), Kevin Song (MM), Anca Prica (Lymphoma), Julie Stakiw (Leukemia), Kylie Lepic (BMT), Denis Soulières (Benign), Wendy Lim (Benign) and Christopher Patriquin (The Complement System).       

This report is written in the language which it was presented.  The content and graphics included are drawn from the respective presenters from CARE at ASH 2017.  Additional perspectives are provided by the CARE Hematology Faculty.